On-chain insurtech Nayms reaches $80m valuation with new token sale
Insurtech Nayms, a fully-regulated marketplace for on-chain insurance, has closed a private token sale at a $80 million valuation, which brings the amount it has raised in total to $12 million.
The funding round was led by UDHC, a DeFi investor headed up by the previous senior team at the Maker Foundation, which developed and deployed the MakerDAO protocol. UDHC is aiming to bring DeFi to the mainstream by funding and guiding projects that are building on established DeFi protocols. Other investors included New Form, Tokentus and Keyrock.
Nayms will use new funds to expand its global team and accelerate the development of its marketplace for crypto-native insurance. The startup is reaching final stages of development before launching a number of insurance programs with the likes of Aon, Breach and Evertas.
"As a fully-regulated marketplace for on-chain insurance, Nayms represents the next major step in risk transfer. Using blockchain technology, Nayms extends traditional risk markets using decentralized tools and features that take risk pricing and management to a new level," said UDHC CEO Steven Becker. "Bringing on-chain capability to traditional markets creating a new, efficient, and transparent financial future is the primary focus of UDHC, and we believe the team at Nayms has the potential to shape that future."
Nayms was the first in the space to hold both the full Digital Asset Business Act license and Innovative Insurer General Business license out of Bermuda, allowing its insurance partners to conduct regulated insurance business on-chain for the first time.
Dan Roberts (pictured), CEO of Nayms, stated: "It is very exciting for us to work more deeply with one of our very first investors and board members. The real experience that the UDHC team has continues to drive us forward as we navigate building and launching our proposition to the market. This round of funding has set us up for an extremely strong 2023, with all the right players behind us."
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze